Omaveloxolone (Synonyms: RTA 408)
目录号: PL11532 纯度: ≥99%
CAS No. :1474034-05-3
商品编号 规格 价格 会员价 是否有货 数量
PL11532-2mg 2mg ¥1591.00 请登录
PL11532-5mg 5mg ¥1768.00 请登录
PL11532-10mg 10mg ¥2732.00 请登录
PL11532-50mg 50mg ¥7875.00 请登录
PL11532-100mg 100mg ¥12697.00 请登录
PL11532-200mg 200mg 询价 询价
PL11532-500mg 500mg 询价 询价
PL11532-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2156.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Omaveloxolone
中文别名
N-(2-氰基-3,12-二氧代-28-去甲齐墩果-1,9(11)-二烯-17-基)-2,2-二氟丙酰胺;Omaveloxolone (RTA-408) 抑制剂
英文名称
Omaveloxolone
英文别名
Omaveloxolone;RTA408;RTA-408
Cas No.
1474034-05-3
分子式
C33H44F2N2O3
分子量
554.71
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Omaveloxolone (RTA 408) 是一种抗氧化炎症调节剂 (AIM),可激活 Nrf2 并抑制一氧化氮 (NO)。Omaveloxolone 通过抑制 STING 依赖的 NF-κb 信号通路,来抑制破骨细胞的生成。
生物活性
Omaveloxolone (RTA 408) is an antioxidant inflammation modulator (AIM), which activates Nrf2 and suppresses nitric oxide (NO). Omaveloxolone attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling.
性状
Solid
IC50 & Target[1][2]
Nrf2
体外研究(In Vitro)
To evaluate the anti-inflammatory activity of Omaveloxolone (RTA 408), RAW 264.7 mouse macrophage cells are treated with Omaveloxolone for two hours and then IFNγ is added to stimulate NO production and release into the media. Omaveloxolone dose-dependently reduces NO concentrations in the media with an IC50 value of 4.4±1.8 nM. The potency of Omaveloxolone in this assay is similar to that of Bardoxolone methyl, which has an IC50 value of 1.9±0.8 nM. Nrf2 activation is required for AIM-mediated NO suppression. A decrease in nitric oxide synthase 2 (Nos2) protein levels is observed in bardoxolone methyl-treated RAW 264.7 cells, which is attenuated when Nrf2 mRNA levels are reduced by siRNA. To evaluate the anticancer activity of Omaveloxolone, a panel of eight human cell lines derived from tumors of different origin are treated with Omaveloxolone and measu
体内研究(In Vivo)
To determine whether Omaveloxolone (RTA-408) is an effective mitigator of hematopoietic acute radiation syndrome after bone marrow-lethal doses of total-body irradiation (TBI), mice are administered 3 daily injections of 17.5 mg/kg Omaveloxolone beginning 24 h after TBI. Teatment with Omaveloxolone results in the 35 day survival of 100% of 7 Gy (LD 40/35 ) TBI mice (P<0.05) and 60% of 7.5 Gy (LD 100/13 ) TBI mice (P<0.0001). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Probst BL, et al. RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity. PLoS One. 2015 Apr 21;10(4):e0122942.
[2]. Peng Han, et al. RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene. Oxid Med Cell Longev. 24 December 2017.
溶解度数据
In Vitro: DMSO : ≥ 100 mg/mL (180.27 mM)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2